Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-39.59	15.51	25.68
Graham Fair Price	41.42	0.24	0.17
PEG	-98.70	0.08	5.80
Price/Book	21.85	1.12	0.92
Price/Cash Flow	39.08	-17.47	-28.67
Prices/Earnings	-39.08	7.52	12.34
Price/Sales	-39.08	1.09	1.79
Price/FCF	39.08	-17.47	-28.67
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-6.71	0.06	0.06
Operating Margin	< 0.005	0.04	0.04
ROA	100.00	0.03	0.01
ROE	0.02	0.04	100.00
ROIC	0.02	0.03	99.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.02	4.03	-99.46
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	16.84	1.00	-94.06
EPS QOQ	0.02	1.00	4600.00
FCF QOQ	-1.37	-1.00	26.83
Revenue QOQ	< 0.005	1.00	45072.17
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-50.21
Days Sales Outstanding (DSO)	163.35	81.85	-49.89
Inventory Turnover	124768000.00	250593000.00	100.85
Debt/Capitalization	0.06	0.06	2.04
Quick Ratio	4.52	4.53	0.20
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.26	0.26	0.00
Cash	0.03	0.03	0.00
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	-0.02	-100.00
Revenue	0.13	0.27	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.53	4.53	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.32	-0.63	52.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating